 | • レポートコード：QAF27780 • 出版社/出版日：QYResearch / 2021年5月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の髄膜炎菌ワクチン市場について種類別（四価、二価、その他）、用途別（肺炎、髄膜炎、細菌血症、その他（関節炎、結膜炎、尿道炎））、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・髄膜炎菌ワクチン市場の概要 ・世界の主要地域別髄膜炎菌ワクチン市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の髄膜炎菌ワクチン市場規模2016-2021：種類別（四価、二価、その他） ・世界の髄膜炎菌ワクチン市場予測2012-2027：種類別（四価、二価、その他） ・世界の髄膜炎菌ワクチン市場規模2016-2021：用途別（肺炎、髄膜炎、細菌血症、その他（関節炎、結膜炎、尿道炎）） ・世界の髄膜炎菌ワクチン市場予測2012-2027：用途別（肺炎、髄膜炎、細菌血症、その他（関節炎、結膜炎、尿道炎）） ・髄膜炎菌ワクチンのアメリカ市場規模と予測2016-2021 ・髄膜炎菌ワクチンのヨーロッパ市場規模と予測2016-2021 ・髄膜炎菌ワクチンの中国市場規模と予測2016-2021 ・髄膜炎菌ワクチンの日本市場規模と予測2016-2021 ・髄膜炎菌ワクチンの東南アジア市場規模と予測2016-2021 ・髄膜炎菌ワクチンのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Novartis、GSK、Merck、CSL、Baxter、JN International Medical Corporation、Serum Institute of India、Bio-Med、China National Biotec Group、Hualan Bio、Walvax、Zhifei） ・髄膜炎菌ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・髄膜炎菌ワクチンの市場動向・機会・課題 ・調査の結論 |
Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.
Market Analysis and Insights: Global Meningococcal Vaccine Market
The global Meningococcal Vaccine market was valued at US$ 262.1 in 2020 and will reach US$ 339.4 million by the end of 2027, growing at a CAGR of 4.4% during 2022-2027.
Global Meningococcal Vaccine Scope and Market Size
The global Meningococcal Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Meningococcal Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Quadrivalent
Bivalent
Others
Segment by Application
Pneumonia
Meningitis
Bacteremia
Others (Arthritis, Conjunctivitis, Urethritis)
The Meningococcal Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Meningococcal Vaccine market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Walvax
Zhifei
1 Meningococcal Vaccine Market Overview
1.1 Meningococcal Vaccine Product Scope
1.2 Meningococcal Vaccine Segment by Type
1.2.1 Global Meningococcal Vaccine Sales by Type (2016 & 2021 & 2027)
1.2.2 Quadrivalent
1.2.3 Bivalent
1.2.4 Others
1.3 Meningococcal Vaccine Segment by Application
1.3.1 Global Meningococcal Vaccine Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Pneumonia
1.3.3 Meningitis
1.3.4 Bacteremia
1.3.5 Others (Arthritis, Conjunctivitis, Urethritis)
1.4 Meningococcal Vaccine Market Estimates and Forecasts (2016-2027)
1.4.1 Global Meningococcal Vaccine Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Meningococcal Vaccine Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Meningococcal Vaccine Price Trends (2016-2027)
2 Meningococcal Vaccine Estimates and Forecasts by Region
2.1 Global Meningococcal Vaccine Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Meningococcal Vaccine Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Meningococcal Vaccine Sales Market Share by Region (2016-2021)
2.2.2 Global Meningococcal Vaccine Revenue Market Share by Region (2016-2021)
2.3 Global Meningococcal Vaccine Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Meningococcal Vaccine Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Meningococcal Vaccine Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Meningococcal Vaccine Estimates and Projections (2016-2027)
2.4.2 Europe Meningococcal Vaccine Estimates and Projections (2016-2027)
2.4.3 China Meningococcal Vaccine Estimates and Projections (2016-2027)
2.4.4 Japan Meningococcal Vaccine Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Meningococcal Vaccine Estimates and Projections (2016-2027)
2.4.6 India Meningococcal Vaccine Estimates and Projections (2016-2027)
3 Global Meningococcal Vaccine Competition Landscape by Players
3.1 Global Top Meningococcal Vaccine Players by Sales (2016-2021)
3.2 Global Top Meningococcal Vaccine Players by Revenue (2016-2021)
3.3 Global Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Meningococcal Vaccine as of 2020)
3.4 Global Meningococcal Vaccine Average Price by Company (2016-2021)
3.5 Manufacturers Meningococcal Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Meningococcal Vaccine Market Size by Type
4.1 Global Meningococcal Vaccine Historic Market Review by Type (2016-2021)
4.1.1 Global Meningococcal Vaccine Sales Market Share by Type (2016-2021)
4.1.2 Global Meningococcal Vaccine Revenue Market Share by Type (2016-2021)
4.1.3 Global Meningococcal Vaccine Price by Type (2016-2021)
4.2 Global Meningococcal Vaccine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Meningococcal Vaccine Sales Forecast by Type (2022-2027)
4.2.2 Global Meningococcal Vaccine Revenue Forecast by Type (2022-2027)
4.2.3 Global Meningococcal Vaccine Price Forecast by Type (2022-2027)
5 Global Meningococcal Vaccine Market Size by Application
5.1 Global Meningococcal Vaccine Historic Market Review by Application (2016-2021)
5.1.1 Global Meningococcal Vaccine Sales Market Share by Application (2016-2021)
5.1.2 Global Meningococcal Vaccine Revenue Market Share by Application (2016-2021)
5.1.3 Global Meningococcal Vaccine Price by Application (2016-2021)
5.2 Global Meningococcal Vaccine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Meningococcal Vaccine Sales Forecast by Application (2022-2027)
5.2.2 Global Meningococcal Vaccine Revenue Forecast by Application (2022-2027)
5.2.3 Global Meningococcal Vaccine Price Forecast by Application (2022-2027)
6 North America Meningococcal Vaccine Market Facts & Figures
6.1 North America Meningococcal Vaccine Sales by Company
6.1.1 North America Meningococcal Vaccine Sales by Company (2016-2021)
6.1.2 North America Meningococcal Vaccine Revenue by Company (2016-2021)
6.2 North America Meningococcal Vaccine Sales Breakdown by Type
6.2.1 North America Meningococcal Vaccine Sales Breakdown by Type (2016-2021)
6.2.2 North America Meningococcal Vaccine Sales Breakdown by Type (2022-2027)
6.3 North America Meningococcal Vaccine Sales Breakdown by Application
6.3.1 North America Meningococcal Vaccine Sales Breakdown by Application (2016-2021)
6.3.2 North America Meningococcal Vaccine Sales Breakdown by Application (2022-2027)
7 Europe Meningococcal Vaccine Market Facts & Figures
7.1 Europe Meningococcal Vaccine Sales by Company
7.1.1 Europe Meningococcal Vaccine Sales by Company (2016-2021)
7.1.2 Europe Meningococcal Vaccine Revenue by Company (2016-2021)
7.2 Europe Meningococcal Vaccine Sales Breakdown by Type
7.2.1 Europe Meningococcal Vaccine Sales Breakdown by Type (2016-2021)
7.2.2 Europe Meningococcal Vaccine Sales Breakdown by Type (2022-2027)
7.3 Europe Meningococcal Vaccine Sales Breakdown by Application
7.3.1 Europe 147 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 147 Sales Breakdown by Application (2022-2027)
8 China Meningococcal Vaccine Market Facts & Figures
8.1 China Meningococcal Vaccine Sales by Company
8.1.1 China Meningococcal Vaccine Sales by Company (2016-2021)
8.1.2 China Meningococcal Vaccine Revenue by Company (2016-2021)
8.2 China Meningococcal Vaccine Sales Breakdown by Type
8.2.1 China Meningococcal Vaccine Sales Breakdown by Type (2016-2021)
8.2.2 China Meningococcal Vaccine Sales Breakdown by Type (2022-2027)
8.3 China Meningococcal Vaccine Sales Breakdown by Application
8.3.1 China 311 Sales Breakdown by Application (2016-2021)
8.3.2 China 311 Sales Breakdown by Application (2022-2027)
9 Japan Meningococcal Vaccine Market Facts & Figures
9.1 Japan Meningococcal Vaccine Sales by Company
9.1.1 Japan Meningococcal Vaccine Sales by Company (2016-2021)
9.1.2 Japan Meningococcal Vaccine Revenue by Company (2016-2021)
9.2 Japan Meningococcal Vaccine Sales Breakdown by Type
9.2.1 Japan Meningococcal Vaccine Sales Breakdown by Type (2016-2021)
9.2.2 Japan Meningococcal Vaccine Sales Breakdown by Type (2022-2027)
9.3 Japan Meningococcal Vaccine Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Meningococcal Vaccine Market Facts & Figures
10.1 Southeast Asia Meningococcal Vaccine Sales by Company
10.1.1 Southeast Asia Meningococcal Vaccine Sales by Company (2016-2021)
10.1.2 Southeast Asia Meningococcal Vaccine Revenue by Company (2016-2021)
10.2 Southeast Asia Meningococcal Vaccine Sales Breakdown by Type
10.2.1 Southeast Asia Meningococcal Vaccine Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Meningococcal Vaccine Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Meningococcal Vaccine Sales Breakdown by Application
10.3.1 Southeast Asia K Dose Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Dose Sales Breakdown by Application (2022-2027)
11 India Meningococcal Vaccine Market Facts & Figures
11.1 India Meningococcal Vaccine Sales by Company
11.1.1 India Meningococcal Vaccine Sales by Company (2016-2021)
11.1.2 India Meningococcal Vaccine Revenue by Company (2016-2021)
11.2 India Meningococcal Vaccine Sales Breakdown by Type
11.2.1 India Meningococcal Vaccine Sales Breakdown by Type (2016-2021)
11.2.2 India Meningococcal Vaccine Sales Breakdown by Type (2022-2027)
11.3 India Meningococcal Vaccine Sales Breakdown by Application
11.3.1 India Meningococcal Vaccine Sales Breakdown by Application (2016-2021)
11.3.2 India Meningococcal Vaccine Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Meningococcal Vaccine Business
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Business Overview
12.1.3 Novartis Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Novartis Meningococcal Vaccine Products Offered
12.1.5 Novartis Recent Development
12.2 GSK
12.2.1 GSK Corporation Information
12.2.2 GSK Business Overview
12.2.3 GSK Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 GSK Meningococcal Vaccine Products Offered
12.2.5 GSK Recent Development
12.3 Merck
12.3.1 Merck Corporation Information
12.3.2 Merck Business Overview
12.3.3 Merck Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Merck Meningococcal Vaccine Products Offered
12.3.5 Merck Recent Development
12.4 CSL
12.4.1 CSL Corporation Information
12.4.2 CSL Business Overview
12.4.3 CSL Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 CSL Meningococcal Vaccine Products Offered
12.4.5 CSL Recent Development
12.5 Baxter
12.5.1 Baxter Corporation Information
12.5.2 Baxter Business Overview
12.5.3 Baxter Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Baxter Meningococcal Vaccine Products Offered
12.5.5 Baxter Recent Development
12.6 JN International Medical Corporation
12.6.1 JN International Medical Corporation Corporation Information
12.6.2 JN International Medical Corporation Business Overview
12.6.3 JN International Medical Corporation Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 JN International Medical Corporation Meningococcal Vaccine Products Offered
12.6.5 JN International Medical Corporation Recent Development
12.7 Serum Institute of India
12.7.1 Serum Institute of India Corporation Information
12.7.2 Serum Institute of India Business Overview
12.7.3 Serum Institute of India Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Serum Institute of India Meningococcal Vaccine Products Offered
12.7.5 Serum Institute of India Recent Development
12.8 Bio-Med
12.8.1 Bio-Med Corporation Information
12.8.2 Bio-Med Business Overview
12.8.3 Bio-Med Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Bio-Med Meningococcal Vaccine Products Offered
12.8.5 Bio-Med Recent Development
12.9 China National Biotec Group
12.9.1 China National Biotec Group Corporation Information
12.9.2 China National Biotec Group Business Overview
12.9.3 China National Biotec Group Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 China National Biotec Group Meningococcal Vaccine Products Offered
12.9.5 China National Biotec Group Recent Development
12.10 Hualan Bio
12.10.1 Hualan Bio Corporation Information
12.10.2 Hualan Bio Business Overview
12.10.3 Hualan Bio Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Hualan Bio Meningococcal Vaccine Products Offered
12.10.5 Hualan Bio Recent Development
12.11 Walvax
12.11.1 Walvax Corporation Information
12.11.2 Walvax Business Overview
12.11.3 Walvax Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Walvax Meningococcal Vaccine Products Offered
12.11.5 Walvax Recent Development
12.12 Zhifei
12.12.1 Zhifei Corporation Information
12.12.2 Zhifei Business Overview
12.12.3 Zhifei Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Zhifei Meningococcal Vaccine Products Offered
12.12.5 Zhifei Recent Development
13 Meningococcal Vaccine Manufacturing Cost Analysis
13.1 Meningococcal Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Meningococcal Vaccine
13.4 Meningococcal Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Meningococcal Vaccine Distributors List
14.3 Meningococcal Vaccine Customers
15 Market Dynamics
15.1 Meningococcal Vaccine Market Trends
15.2 Meningococcal Vaccine Drivers
15.3 Meningococcal Vaccine Market Challenges
15.4 Meningococcal Vaccine Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Meningococcal Vaccine Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Meningococcal Vaccine Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Meningococcal Vaccine Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Meningococcal Vaccine Sales (K Dose) by Region (2016-2021)
Table 5. Global Meningococcal Vaccine Sales Market Share by Region (2016-2021)
Table 6. Global Meningococcal Vaccine Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Meningococcal Vaccine Revenue Share by Region (2016-2021)
Table 8. Global Meningococcal Vaccine Sales (K Dose) Forecast by Region (2022-2027)
Table 9. Global Meningococcal Vaccine Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Meningococcal Vaccine Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Meningococcal Vaccine Revenue Share Forecast by Region (2022-2027)
Table 12. Global Meningococcal Vaccine Sales (K Dose) of Key Companies (2016-2021)
Table 13. Global Meningococcal Vaccine Sales Share by Company (2016-2021)
Table 14. Global Meningococcal Vaccine Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Meningococcal Vaccine Revenue Share by Company (2016-2021)
Table 16. Global Meningococcal Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Vaccine as of 2020)
Table 17. Global Meningococcal Vaccine Average Price (USD/Dose) of Key Company (2016-2021)
Table 18. Manufacturers Meningococcal Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers Meningococcal Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Meningococcal Vaccine Sales (K Dose) by Type (2016-2021)
Table 22. Global Meningococcal Vaccine Sales Share by Type (2016-2021)
Table 23. Global Meningococcal Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Meningococcal Vaccine Price (USD/Dose) by Type (2016-2021)
Table 25. Global Meningococcal Vaccine Sales Share by Type (2022-2027)
Table 26. Global Meningococcal Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Meningococcal Vaccine Revenue Share by Type (2022-2027)
Table 28. Global Meningococcal Vaccine Price (USD/Dose) by Type (2022-2027)
Table 29. Global Meningococcal Vaccine Sales (K Dose) by Application (2016-2021)
Table 30. Global Meningococcal Vaccine Sales Share by Application (2016-2021)
Table 31. Global Meningococcal Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Meningococcal Vaccine Price (USD/Dose) by Application (2016-2021)
Table 33. Global Meningococcal Vaccine Sales (K Dose) by Application (2022-2027)
Table 34. Global Meningococcal Vaccine Sales Share by Application (2022-2027)
Table 35. Global Meningococcal Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Meningococcal Vaccine Revenue Share by Application (2022-2027)
Table 37. Global Meningococcal Vaccine Price (USD/Dose) by Application (2022-2027)
Table 38. North America Meningococcal Vaccine Sales (K Dose) by Company (2016-2021)
Table 39. North America Meningococcal Vaccine Sales Market Share by Company (2016-2021)
Table 40. North America Meningococcal Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Meningococcal Vaccine Revenue Market Share by Company (2016-2021)
Table 42. North America Meningococcal Vaccine Sales by Type (2016-2021) & (K Dose)
Table 43. North America Meningococcal Vaccine Sales Market Share by Type (2016-2021)
Table 44. North America Meningococcal Vaccine Sales by Type (2022-2027) & (K Dose)
Table 45. North America Meningococcal Vaccine Sales Market Share by Type (2022-2027)
Table 46. North America Meningococcal Vaccine Sales by Application (2016-2021) & (K Dose)
Table 47. North America Meningococcal Vaccine Sales Market Share by Application (2016-2021)
Table 48. North America Meningococcal Vaccine Sales by Application (2022-2027) & (K Dose)
Table 49. North America Meningococcal Vaccine Sales Market Share by Application (2022-2027)
Table 50. Europe Meningococcal Vaccine Sales (K Dose) by Company (2016-2021)
Table 51. Europe Meningococcal Vaccine Sales Market Share by Company (2016-2021)
Table 52. Europe Meningococcal Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Meningococcal Vaccine Revenue Market Share by Company (2016-2021)
Table 54. Europe Meningococcal Vaccine Sales by Type (2016-2021) & (K Dose)
Table 55. Europe Meningococcal Vaccine Sales Market Share by Type (2016-2021)
Table 56. Europe Meningococcal Vaccine Sales by Type (2022-2027) & (K Dose)
Table 57. Europe Meningococcal Vaccine Sales Market Share by Type (2022-2027)
Table 58. Europe Meningococcal Vaccine Sales by Application (2016-2021) & (K Dose)
Table 59. Europe Meningococcal Vaccine Sales Market Share by Application (2016-2021)
Table 60. Europe Meningococcal Vaccine Sales by Application (2022-2027) & (K Dose)
Table 61. Europe Meningococcal Vaccine Sales Market Share by Application (2022-2027)
Table 62. China Meningococcal Vaccine Sales (K Dose) by Company (2016-2021)
Table 63. China Meningococcal Vaccine Sales Market Share by Company (2016-2021)
Table 64. China Meningococcal Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Meningococcal Vaccine Revenue Market Share by Company (2016-2021)
Table 66. China Meningococcal Vaccine Sales by Type (2016-2021) & (K Dose)
Table 67. China Meningococcal Vaccine Sales Market Share by Type (2016-2021)
Table 68. China Meningococcal Vaccine Sales by Type (2022-2027) & (K Dose)
Table 69. China Meningococcal Vaccine Sales Market Share by Type (2022-2027)
Table 70. China Meningococcal Vaccine Sales by Application (2016-2021) & (K Dose)
Table 71. China Meningococcal Vaccine Sales Market Share by Application (2016-2021)
Table 72. China Meningococcal Vaccine Sales by Application (2022-2027) & (K Dose)
Table 73. China Meningococcal Vaccine Sales Market Share by Application (2022-2027)
Table 74. Japan Meningococcal Vaccine Sales (K Dose) by Company (2016-2021)
Table 75. Japan Meningococcal Vaccine Sales Market Share by Company (2016-2021)
Table 76. Japan Meningococcal Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Meningococcal Vaccine Revenue Market Share by Company (2016-2021)
Table 78. Japan Meningococcal Vaccine Sales by Type (2016-2021) & (K Dose)
Table 79. Japan Meningococcal Vaccine Sales Market Share by Type (2016-2021)
Table 80. Japan Meningococcal Vaccine Sales by Type (2022-2027) & (K Dose)
Table 81. Japan Meningococcal Vaccine Sales Market Share by Type (2022-2027)
Table 82. Japan Meningococcal Vaccine Sales by Application (2016-2021) & (K Dose)
Table 83. Japan Meningococcal Vaccine Sales Market Share by Application (2016-2021)
Table 84. Japan Meningococcal Vaccine Sales by Application (2022-2027) & (K Dose)
Table 85. Japan Meningococcal Vaccine Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Meningococcal Vaccine Sales (K Dose) by Company (2016-2021)
Table 87. Southeast Asia Meningococcal Vaccine Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Meningococcal Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Meningococcal Vaccine Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Meningococcal Vaccine Sales by Type (2016-2021) & (K Dose)
Table 91. Southeast Asia Meningococcal Vaccine Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Meningococcal Vaccine Sales by Type (2022-2027) & (K Dose)
Table 93. Southeast Asia Meningococcal Vaccine Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Meningococcal Vaccine Sales by Application (2016-2021) & (K Dose)
Table 95. Southeast Asia Meningococcal Vaccine Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Meningococcal Vaccine Sales by Application (2022-2027) & (K Dose)
Table 97. Southeast Asia Meningococcal Vaccine Sales Market Share by Application (2022-2027)
Table 98. India Meningococcal Vaccine Sales (K Dose) by Company (2016-2021)
Table 99. India Meningococcal Vaccine Sales Market Share by Company (2016-2021)
Table 100. India Meningococcal Vaccine Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Meningococcal Vaccine Revenue Market Share by Company (2016-2021)
Table 102. India Meningococcal Vaccine Sales by Type (2016-2021) & (K Dose)
Table 103. India Meningococcal Vaccine Sales Market Share by Type (2016-2021)
Table 104. India Meningococcal Vaccine Sales by Type (2022-2027) & (K Dose)
Table 105. India Meningococcal Vaccine Sales Market Share by Type (2022-2027)
Table 106. India Meningococcal Vaccine Sales by Application (2016-2021) & (K Dose)
Table 107. India Meningococcal Vaccine Sales Market Share by Application (2016-2021)
Table 108. India Meningococcal Vaccine Sales by Application (2022-2027) & (K Dose)
Table 109. India Meningococcal Vaccine Sales Market Share by Application (2022-2027)
Table 110. Novartis Corporation Information
Table 111. Novartis Description and Business Overview
Table 112. Novartis Meningococcal Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 113. Novartis Meningococcal Vaccine Product
Table 114. Novartis Recent Development
Table 115. GSK Corporation Information
Table 116. GSK Description and Business Overview
Table 117. GSK Meningococcal Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 118. GSK Meningococcal Vaccine Product
Table 119. GSK Recent Development
Table 120. Merck Corporation Information
Table 121. Merck Description and Business Overview
Table 122. Merck Meningococcal Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 123. Merck Meningococcal Vaccine Product
Table 124. Merck Recent Development
Table 125. CSL Corporation Information
Table 126. CSL Description and Business Overview
Table 127. CSL Meningococcal Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 128. CSL Meningococcal Vaccine Product
Table 129. CSL Recent Development
Table 130. Baxter Corporation Information
Table 131. Baxter Description and Business Overview
Table 132. Baxter Meningococcal Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 133. Baxter Meningococcal Vaccine Product
Table 134. Baxter Recent Development
Table 135. JN International Medical Corporation Corporation Information
Table 136. JN International Medical Corporation Description and Business Overview
Table 137. JN International Medical Corporation Meningococcal Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 138. JN International Medical Corporation Meningococcal Vaccine Product
Table 139. JN International Medical Corporation Recent Development
Table 140. Serum Institute of India Corporation Information
Table 141. Serum Institute of India Description and Business Overview
Table 142. Serum Institute of India Meningococcal Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 143. Serum Institute of India Meningococcal Vaccine Product
Table 144. Serum Institute of India Recent Development
Table 145. Bio-Med Corporation Information
Table 146. Bio-Med Meningococcal Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 147. Bio-Med Description and Business Overview
Table 148. Bio-Med Meningococcal Vaccine Product
Table 149. Bio-Med Recent Development
Table 150. China National Biotec Group Corporation Information
Table 151. China National Biotec Group Meningococcal Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 152. China National Biotec Group Description and Business Overview
Table 153. China National Biotec Group Meningococcal Vaccine Product
Table 154. China National Biotec Group Recent Development
Table 155. Hualan Bio Corporation Information
Table 156. Hualan Bio Description and Business Overview
Table 157. Hualan Bio Meningococcal Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 158. Hualan Bio Meningococcal Vaccine Product
Table 159. Hualan Bio Recent Development
Table 160. Walvax Corporation Information
Table 161. Walvax Description and Business Overview
Table 162. Walvax Meningococcal Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 163. Walvax Meningococcal Vaccine Product
Table 164. Walvax Recent Development
Table 165. Zhifei Corporation Information
Table 166. Zhifei Description and Business Overview
Table 167. Zhifei Meningococcal Vaccine Sales (K Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2016-2021)
Table 168. Zhifei Meningococcal Vaccine Product
Table 169. Zhifei Recent Development
Table 170. Production Base and Market Concentration Rate of Raw Material
Table 171. Key Suppliers of Raw Materials
Table 172. Meningococcal Vaccine Distributors List
Table 173. Meningococcal Vaccine Customers List
Table 174. Meningococcal Vaccine Market Trends
Table 175. Meningococcal Vaccine Market Drivers
Table 176. Meningococcal Vaccine Market Challenges
Table 177. Meningococcal Vaccine Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Meningococcal Vaccine Product Picture
Figure 2. Global Meningococcal Vaccine Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Meningococcal Vaccine Sales Market Share by Application in 2021 & 2027
Figure 6. Pneumonia Examples
Figure 7. Meningitis Examples
Figure 8. Bacteremia Examples
Figure 9. Others (Arthritis, Conjunctivitis, Urethritis) Examples
Figure 10. Global Meningococcal Vaccine Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Meningococcal Vaccine Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Meningococcal Vaccine Sales (K Dose) Growth Rate (2016-2027)
Figure 13. Global Meningococcal Vaccine Price Trends Growth Rate (2016-2027) (USD/Dose)
Figure 14. Global Meningococcal Vaccine Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Meningococcal Vaccine Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Meningococcal Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Meningococcal Vaccine Sales (K Dose) Growth Rate (2016-2027)
Figure 18. Europe Meningococcal Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Meningococcal Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Meningococcal Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Meningococcal Vaccine Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Meningococcal Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Meningococcal Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Meningococcal Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Meningococcal Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Meningococcal Vaccine Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Meningococcal Vaccine Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Meningococcal Vaccine Players Market Share by Revenue in Meningococcal Vaccine: 2016 & 2020
Figure 29. Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Meningococcal Vaccine Revenue Share by Type (2016-2021)
Figure 31. Global Meningococcal Vaccine Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Meningococcal Vaccine Revenue Share by Application (2016-2021)
Figure 33. Global Meningococcal Vaccine Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Meningococcal Vaccine Sales Market Share by Type in 2020
Figure 35. North America Meningococcal Vaccine Sales Market Share by Application in 2020
Figure 36. Europe Meningococcal Vaccine Sales Market Share by Type in 2020
Figure 37. Europe Meningococcal Vaccine Sales Market Share by Application in 2020
Figure 38. China Meningococcal Vaccine Sales Market Share by Type in 2020
Figure 39. China Meningococcal Vaccine Sales Market Share by Application in 2020
Figure 40. Japan Meningococcal Vaccine Sales Market Share by Type in 2020
Figure 41. Japan Meningococcal Vaccine Sales Market Share by Application in 2020
Figure 42. Southeast Asia Meningococcal Vaccine Sales Market Share by Type in 2020
Figure 43. Southeast Asia Meningococcal Vaccine Sales Market Share by Application in 2020
Figure 44. India Meningococcal Vaccine Sales Market Share by Type in 2020
Figure 45. India Meningococcal Vaccine Sales Market Share by Application in 2020
Figure 46. Key Raw Materials Price Trend
Figure 47. Manufacturing Cost Structure of Meningococcal Vaccine
Figure 48. Manufacturing Process Analysis of Meningococcal Vaccine
Figure 49. Meningococcal Vaccine Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed